Transcatheter Aortic Valve Replacement (TAVR)

Aor­tic Steno­sis occurs when the aor­tic valve begins to nar­row, reduc­ing blood flow from your heart to the rest of your body, caus­ing symp­toms and weak­en­ing your heart mus­cle. Some symp­toms of aor­tic steno­sis include heart mur­murs, chest pain, feel­ing faint or dizzy, short­ness of breath and fatigue. In some cas­es, aor­tic valve replace­ment surgery is nec­es­sary, but upon con­sul­ta­tion your doc­tor may be able to per­form a less-inva­sive pro­ce­dure called tran­scatheter aor­tic valve replace­ment (TAVR). TAVR is approved by the Food and Drug Admin­is­tra­tion (FDA) for peo­ple with aor­tic steno­sis who are not can­di­dates for open-heart valve replace­ment surgery.

Ben­e­fits of TAVR:

• Min­i­mal­ly inva­sive catheter-based valve replacement
• Quick recov­ery-aver­age length of stay is 1 – 3 days
• Faster recov­ery with less pain

To learn more about TAVR and the tech­nol­o­gy we use, please vis­it Medtron​ic​.com or New​Heart​Valve​.com.